首页> 外文期刊>Urology >Effect of antiepileptic agent, levetiracetam, on urodynamic parameters and neurogenic bladder overactivity in chronically paraplegic rats.
【24h】

Effect of antiepileptic agent, levetiracetam, on urodynamic parameters and neurogenic bladder overactivity in chronically paraplegic rats.

机译:抗癫痫药左乙拉西坦对慢性截瘫大鼠尿动力学参数和神经源性膀胱过度活动的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To investigate the effects of different levetiracetam (LEV) doses on urodynamic parameters in an animal model of neurogenic detrusor overactivity (NDO). METHODS: A total of 54 female rats were studied. Of the 54 rats, 6 served as normal controls, and 48 underwent T10 spinal cord transection (SCT). Of the latter 48 rats, 12 were paraplegic controls, and the remaining 36 rats were divided into 3 equal subgroups that received LEV by way of a subcutaneous osmotic minipump at a dose of 17, 54, and 108 mg/kg daily, respectively. The paraplegic control and treatment groups were further subdivided (n = 6), and cystometry was performed at 3 and 4 weeks after SCT, respectively. RESULTS: All paraplegic controls developed NDO, with spontaneous contractions. At 3 and 4 weeks after SCT, the mean frequency of the contractions was 1.6 +/- 0.3/min and 1.7 +/- 0.2/min. The contraction amplitude and bladder capacity were not significantly different. After 1 week of LEV treatment, these urodynamic parameters improved significantly in a dose-dependent manner, and the changes were more striking at 2 weeks. At a LEV dosage of 17, 54, and 108 mg/kg, respectively, the NDO frequency increased from 1.7 +/- 0.3 to 0.7 +/- 0.2 contractions/min (P = .01), 0.48 +/- 0.16 contractions/min (P = .009), and 0.5 +/- 0.17 contractions/min (P = .01). The bladder capacity increased from 0.51 +/- 0.1 mL to 1.5 +/- 0.2 mL (P = .0001), 2.5 +/- 1.7 mL (P = .006), and 2.6 +/- 0.3 mL (P = .0003), and the micturition pressure improved from 105.8 +/- 6.9 to 73.8 +/- 6.8 cm H(2)O (P = .01), 58.6 +/- 8.9 cm H(2)O (P = .006), and 49.7 +/- 8.9 cm H(2)O (P = .002). CONCLUSIONS: The results of our study have shown that LEV is an effective treatment of NDO after SCT in rats. It might prove to be a novel, alternative therapeutic approach to NDO. The follow-up of these experimental results with a clinical trial is warranted.
机译:目的:在神经源性逼尿肌过度活动(NDO)动物模型中,研究不同剂量的左乙拉西坦(LEV)对尿动力学参数的影响。方法:对54只雌性大鼠进行了研究。在54只大鼠中,有6只作为正常对照,其中48只接受了T10脊髓横断(SCT)。在后48只大鼠中,有12只是截瘫对照,其余36只大鼠被分为3个相同的亚组,分别通过皮下渗透微型泵分别接受LEV,分别为17、54和108 mg / kg的剂量。截瘫对照组和治疗组进一步细分(n = 6),分别在SCT后3周和4周进行膀胱测压。结果:所有截瘫对照均发生了NDO,并伴有自然收缩。 SCT后3和4周,平均收缩频率为1.6 +/- 0.3 / min和1.7 +/- 0.2 / min。收缩幅度和膀胱容量无明显差异。 LEV治疗1周后,这些尿动力学参数以剂量依赖性方式显着改善,并且在2周时变化更为明显。在LEV剂量分别为17、54和108 mg / kg时,NDO频率从1.7 +/- 0.3收缩增加到0.7 +/- 0.2收缩/分钟(P = .01),0.48 +/- 0.16收缩/分钟(P = .009)和0.5 +/- 0.17收缩/分钟(P = .01)。膀胱容量从0.51 +/- 0.1 mL增加到1.5 +/- 0.2 mL(P = .0001),2.5 +/- 1.7 mL(P = .006)和2.6 +/- 0.3 mL(P = .0003) ),排尿压力从105.8 +/- 6.9厘米提高到73.8 +/- 6.8厘米H(2)O(P = .01),58.6 +/- 8.9厘米H(2)O(P = .006),和49.7 +/- 8.9 cm H(2)O(P = .002)。结论:我们的研究结果表明LEV是大鼠SCT后NDO的有效治疗方法。它可能被证明是NDO的一种新颖的替代治疗方法。这些实验结果需要进行临床随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号